Clinical studies are an essential part of the development process to determine if an investigational treatment should be approved for use in the general population. Neurocrine UK, as part of the Neurocrine Biosciences Group, conducts clinical trials across the UK, Europe and the US and publishes the protocols and results from its trials across various public databases and registries.
Please note clinical trials registered before October 2024 may be under the company legacy name of Diurnal.
UK
The NHS Research Authority database